116 related articles for article (PubMed ID: 38269478)
21. Hsa-miR-194-5p and hsa-miR-195-5p are down-regulated expressed in high dysplasia HPV-positive Pap smear samples compared to normal cytology HPV-positive Pap smear samples.
Dehghani A; Khajepour F; Dehghani M; Razmara E; Zangouey M; Abadi MFS; Nezhad RBA; Dabiri S; Garshasbi M
BMC Infect Dis; 2024 Feb; 24(1):182. PubMed ID: 38342922
[TBL] [Abstract][Full Text] [Related]
22. NOVAprep-miR-Cervix: New Method for Evaluation of Cervical Dysplasia Severity Based on Analysis of Six miRNAs.
Kniazeva M; Zabegina L; Shalaev A; Smirnova O; Lavrinovich O; Berlev I; Malek A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298066
[TBL] [Abstract][Full Text] [Related]
23. Application of Color Doppler Ultrasound in Microscopic Imaging Diagnosis of Adenomyosis.
Zhu J; Liu S; Gao D
Scanning; 2022; 2022():2366871. PubMed ID: 35692699
[TBL] [Abstract][Full Text] [Related]
24. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer.
Li M; Li Q; Yin Q; Wang Y; Shang JM; Wang LH
Clin Transl Oncol; 2021 Apr; 23(4):709-717. PubMed ID: 33206330
[TBL] [Abstract][Full Text] [Related]
26. Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer.
Farzanehpour M; Mozhgani SH; Jalilvand S; Faghihloo E; Akhavan S; Salimi V; Azad TM
Virol J; 2019 Oct; 16(1):116. PubMed ID: 31590680
[TBL] [Abstract][Full Text] [Related]
27. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
[TBL] [Abstract][Full Text] [Related]
28. Intratumoral blood flow in cervical cancer as assessed by transvaginal color doppler ultrasonography: Correlation with tumor characteristics.
Alcázar JL; Castillo G; Jurado M; López-García G
Int J Gynecol Cancer; 2003; 13(4):510-4. PubMed ID: 12911729
[TBL] [Abstract][Full Text] [Related]
29. CAFs-derived exosomes promote the development of cervical cancer by regulating miR-18a-5p-TMEM170B signaling axis.
Kang C; Duo Y; Zheng L; Zhao N; Wang J; Liu Z; Qiu L; Bi F
Biochem Biophys Res Commun; 2024 Jan; 694():149403. PubMed ID: 38147699
[TBL] [Abstract][Full Text] [Related]
30. Value of Diffusion-Weighted Magnetic Resonance Imaging Combined with miR-18a Level in Predicting Radiosensitivity of Cervical Cancer.
Bu X; Zhang J; Tian F; Wang X; Wu L; Tian W
Med Sci Monit; 2018 Oct; 24():7271-7278. PubMed ID: 30308669
[TBL] [Abstract][Full Text] [Related]
31. High Expression of Circular RNA-Mitochondrial tRNA Translation Optimization 1 Assists the Diagnosis of High-Risk Human Papillomavirus Infection in Cervical Cancer.
Cheng X; Shen C; Liao Z
J Low Genit Tract Dis; 2022 Jul; 26(3):212-218. PubMed ID: 35384929
[TBL] [Abstract][Full Text] [Related]
32. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
[TBL] [Abstract][Full Text] [Related]
33. Detection of Cervical Lesions and Cancer in Air-Dried Cytologic Smears by Combined Analysis of mRNA and miRNA Expression Levels.
Ivanov MK; Titov SE; Dzyubenko VV; Glushkov SA; Krasilnikov SE; Mansurova AS; Malek AV; Berlev IV; Prisyazhnaya TS; Kuleshova SV; Hodkevich AA; Lancuhaj YA; Dimitriadi TA; Agletdinov EF
J Mol Diagn; 2021 May; 23(5):541-554. PubMed ID: 33662584
[TBL] [Abstract][Full Text] [Related]
34. MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression.
Zhu Y; Han Y; Tian T; Su P; Jin G; Chen J; Cao Y
Pathol Res Pract; 2018 Mar; 214(3):374-379. PubMed ID: 29487007
[TBL] [Abstract][Full Text] [Related]
35. Assessment of cervical volume and spectral Doppler parameters in tumour dominant vessel of patients with locally advanced squamous cell cervical carcinoma.
Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
J Obstet Gynaecol; 2021 Oct; 41(7):1116-1120. PubMed ID: 33427547
[TBL] [Abstract][Full Text] [Related]
36. Three-dimensional power Doppler ultrasound in cervical carcinoma: monitoring treatment response to radiotherapy.
Huang YF; Cheng YM; Wu YP; Chen HH; Hsu KF; Wu YH; Chou CY
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):84-92. PubMed ID: 22744872
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of blood flow in uterine arteries in patients with cancer of the cervix uteri using transvaginal color doppler ultrasonography].
Szpurek D; Olejnik M; Roszak A; Dańska A; Spaczyński M
Ginekol Pol; 1995 Sep; 66(9):529-32. PubMed ID: 8778010
[TBL] [Abstract][Full Text] [Related]
38. Pap Smear miR-92a-5p and miR-155-5p as potential diagnostic biomarkers of squamous intraepithelial cervical cancer.
Azimi T; Paryan M; Mondanizadeh M; Sarmadian H; Zamani A
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1271-1277. PubMed ID: 33906322
[TBL] [Abstract][Full Text] [Related]
39. Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening.
Carter JR; Lau M; Fowler JM; Carlson JW; Carson LF; Twiggs LB
Am J Obstet Gynecol; 1995 Mar; 172(3):901-7. PubMed ID: 7892883
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic value of transvaginal color Doppler ultrasonography plus serum β-HCG dynamic monitoring in intrauterine residue after medical abortion.
Liu Y; Lv W
Medicine (Baltimore); 2023 Feb; 102(5):e31217. PubMed ID: 36749252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
